DKK693.40
1.00% today
Copenhagen, Apr 04, 04:59 pm CET
ISIN
DK0060448595
Symbol
COLO B
Sector

Coloplast A/S B Stock price

DKK693.40
-77.20 10.02% 1M
-169.20 19.62% 6M
-92.80 11.80% YTD
-227.40 24.70% 1Y
-348.10 33.42% 3Y
-315.60 31.28% 5Y
+170.63 32.64% 10Y
Copenhagen, Closing price Fri, Apr 04 2025
-7.00 1.00%
ISIN
DK0060448595
Symbol
COLO B
Sector

Key metrics

Market capitalization DKK157.85b
Enterprise Value DKK176.70b
P/E (TTM) P/E ratio 32.26
EV/FCF (TTM) EV/FCF 99.44
EV/Sales (TTM) EV/Sales 6.44
P/S ratio (TTM) P/S ratio 5.75
P/B ratio (TTM) P/B ratio 10.21
Dividend yield 3.00%
Last dividend (FY24) DKK21.00
Revenue growth (TTM) Revenue growth 9.80%
Revenue (TTM) Revenue DKK27.45b
EBIT (operating result TTM) EBIT DKK7.51b
Free Cash Flow (TTM) Free Cash Flow DKK1.78b
Cash position DKK906.00m
EPS (TTM) EPS DKK21.71
P/E forward 34.36
P/S forward 5.44
EV/Sales forward 6.09
Show more

Is Coloplast A/S B a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

Coloplast A/S B Stock Analysis

Unlock Scores for Free

Analyst Opinions

26 Analysts have issued a Coloplast A/S B forecast:

12x Buy
46%
11x Hold
42%
3x Sell
12%

Analyst Opinions

26 Analysts have issued a Coloplast A/S B forecast:

Buy
46%
Hold
42%
Sell
12%

Financial data from Coloplast A/S B

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
27,450 27,450
10% 10%
100%
- Direct Costs 8,935 8,935
7% 7%
33%
18,515 18,515
11% 11%
67%
- Selling and Administrative Expenses 8,920 8,920
14% 14%
32%
- Research and Development Expense 899 899
1% 1%
3%
8,819 8,819
11% 11%
32%
- Depreciation and Amortization 1,310 1,310
17% 17%
5%
EBIT (Operating Income) EBIT 7,509 7,509
10% 10%
27%
Net Profit 4,884 4,884
0% 0%
18%

In millions DKK.

Don't miss a Thing! We will send you all news about Coloplast A/S B directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Coloplast A/S develops, manufactures, and markets medical products. It operates through the following segments: Chronic Care, Interventional Urology and Wound & Skin Care. The Chronic Care segment covers the sale of ostomy care products and continence care products. The Interventional Urology segment covers the sale of urological products, including disposable products. The Wound & Skin Care segment covers the sale of wound and skin care products. The company was founded by Aage Louis-Hansen and Johanne Louise-Hansen in 1954 and is headquartered in Humlebaek, Denmark.

Head office Denmark
CEO Kristian Villumsen
Employees 16,639
Founded 1957
Website www.coloplast.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today